MYCOSIS FUNGOIDES/SEZARY SYNDROME
Clinical trials for MYCOSIS FUNGOIDES/SEZARY SYNDROME explained in plain language.
Never miss a new study
Get alerted when new MYCOSIS FUNGOIDES/SEZARY SYNDROME trials appear
Sign up with your email to follow new studies for MYCOSIS FUNGOIDES/SEZARY SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill takes on rare skin cancer in early trial
Disease control OngoingThis early-phase study tests a new drug called tulmimetostat (DZR123) in 24 adults with advanced mycosis fungoides or Sézary syndrome—rare types of skin lymphoma—who have already tried at least one other treatment. The main goals are to check the drug's safety and find the best d…
Matched conditions: MYCOSIS FUNGOIDES/SEZARY SYNDROME
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 08:34 UTC
-
Promising combo targets rare skin cancer
Disease control OngoingThis study tests whether combining two drugs, pembrolizumab and gemcitabine, can shrink tumors in people with advanced mycosis fungoides or Sézary syndrome—rare types of skin lymphoma. The trial enrolled 14 adults who had already tried at least one other treatment. Researchers ar…
Matched conditions: MYCOSIS FUNGOIDES/SEZARY SYNDROME
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 19, 2026 11:47 UTC